GlassScriptPhysician profile
Gregory S Sextro
NPI 1104829563
$4,066.33
in general payments reported to CMS, 2019-2025
25 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $1,030 · 2021: $679 · 2022: $467 · 2023: $504 · 2024: $361 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030 · Travel and Lodging: $126 · Education: $68.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.62 |
| Travel and Lodging | $126.44 |
| Education | $68.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,946.12 | 2019-2025 | Actis, Va-Lcp, Na |
| Stryker Corporation | $755.87 | 2019-2025 | Gamma, Axsos, Variax |
| Musculoskeletal Transplant Foundation INC. | $232.67 | 2021 | |
| Medical Device Business Services, INC. | $209.07 | 2021-2023 | Inhance |
| Conetic Solutions, INC. | $144.01 | 2021-2025 | |
| Heron Therapeutics, INC. | $102.21 | 2021-2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $97.88 | 2019-2023 | Iovera, Zilretta, Exparel |
| Vericel Corporation | $81.94 | 2020-2025 | Maci |
| Smith+Nephew, INC. | $78.69 | 2019-2024 | Pico, Renasys Go V2 Home, Bone Anchors With Arthroscopic Delivery System |
| Cerapedics INC. | $75.09 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Vertex Pharmaceuticals Incorporated | $41.62 | 2025 | |
| Integra Lifesciences Corporation | $30.46 | 2022 | |
| Pacira Cryotech Incorporated | $30.26 | 2019 | |
| Organogenesis INC. | $28.12 | 2025 | Puraply Wound Matrix |
| Kerecis Limited | $27.74 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $24.92 | 2020 | |
| Ferring Pharmaceuticals INC. | $23.95 | 2021 | |
| Bioventus LLC | $22.49 | 2019 | |
| Kci USA, INC. | $20.92 | 2020 | |
| Linvatec Corporation | $17.94 | 2022 | |
| Zimmer Biomet Holdings, INC. | $17.05 | 2025 | Osseofit |
| Ultragenyx Pharmaceutical INC. | $15.45 | 2021 | |
| Medtronic, INC. | $14.92 | 2024 | Plasmablade(Tm) |
| Aveo Pharmaceuticals, INC. | $13.51 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Sextro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.